ClinicalTrials.Veeva

Menu

Developing a PrEP Adherence Intervention Targeting At-Risk and Substance Using Women (PEARL)

Johns Hopkins Bloomberg School of Public Health logo

Johns Hopkins Bloomberg School of Public Health

Status

Completed

Conditions

HIV/AIDS

Treatments

Behavioral: PrEP standard of care+behavioral intervention

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to develop and assess the feasibility, acceptability, and preliminary efficacy on adherence of a community-informed intervention for tenofovir/emtricitabine (TDF/FTC) pre-exposure prophylaxis (PrEP) engagement among street-based female sex workers (FSW) in Baltimore, Maryland.

Full description

This study is a prospective two-group trial comparing the efficacy of a comprehensive PrEP adherence program compared to PrEP standard of care among FSW. Outcomes will be assessed through self-reported PrEP adherence as well as biological adherence indicators.

The intervention includes three main components: 1) group PrEP engagement sessions, which include four educational sessions that situate PrEP in a broader framework of access and barriers to care, provider/patient communication, sexual health, HIV/sexually transmitted infection (STI) education, harm reduction around drug use, stigma, risk compensation and safe sex, and health/science literacy; 2) peer navigation, which aims to help women navigate healthcare engagement with the SPARC nurse practitioner and other providers; and 3) an mHealth component, consisting of a two-way text messaging system through which women will receive automated daily messages and weekly messages requesting adherence reports.

Enrollment

39 patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 18 or older
  • Assigned female at birth and identify as a woman
  • Traded sex for money or drugs at least three times in the past three months
  • HIV negative
  • Willing to initiate PrEP
  • Not knowingly pregnant or planning to become pregnant during the following 6 months.

Exclusion criteria

  • Currently taking PrEP for HIV prevention
  • Inability to provide informed consent in English
  • Women who are determined as too high or drunk
  • Women who are cognitively impaired
  • Does not agree to data sharing with the Baltimore City Health Department

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

39 participants in 2 patient groups

PrEP Standard of Care
No Intervention group
Description:
PrEP standard of care, administered through the Baltimore City Health Department
PrEP standard of care+behavioral intervention
Experimental group
Description:
PrEP standard of care, administered through the Baltimore City Health Department, and the behavioral intervention.
Treatment:
Behavioral: PrEP standard of care+behavioral intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems